Market revenue in 2021 | USD 278.1 million |
Market revenue in 2028 | USD 824.8 million |
Growth rate | 16.8% (CAGR from 2021 to 2028) |
Largest segment | Left ventricular assist devices |
Fastest growing segment | Total Artificial Heart (TAH) |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Left ventricular assist devices, Right ventricular assist devices, Bi-ventricular assist devices, Total Artificial Heart (TAH) |
Key market players worldwide | Johnson & Johnson, Medtronic PLC, Abbott Laboratories, Cardio Diagnostics Holdings Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ventricular assist device market will help companies and investors design strategic landscapes.
Left ventricular assist devices was the largest segment with a revenue share of 79.68% in 2021. Horizon Databook has segmented the Germany ventricular assist device market based on left ventricular assist devices, right ventricular assist devices, bi-ventricular assist devices, total artificial heart (tah) covering the revenue growth of each sub-segment from 2018 to 2028.
The presence of high-quality healthcare infrastructure and favorable reimbursement policies are key factors expected to drive this market. As per World Bank healthcare expenditure as total (% of GDP) estimates, Germany allocates nearly 11.4% of GDP toward healthcare expenditure in 2018.
According to International Society for Pharmacoeconomics and Outcomes Research (ISPOR), in November 2020, over 90% of total population was reportedly covered by Statutory Health Insurance Fund (SHIF) and less than 10% were covered by private insurance.
Furthermore, it was also reported that pharmaceutical spending was reduced from preceding year due to the implementation of a new law for raising compulsory rebates for pharmaceutical manufacturers.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany ventricular assist device market , including forecasts for subscribers. This country databook contains high-level insights into Germany ventricular assist device market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account